Provided by Tiger Trade Technology Pte. Ltd.

Edwards Lifesciences

90.75
+0.54000.60%
Post-market: 91.000.2500+0.28%19:50 EDT
Volume:4.05M
Turnover:367.50M
Market Cap:52.32B
PE:52.79
High:91.29
Open:91.00
Low:89.32
Close:90.21
52wk High:96.29
52wk Low:72.30
Shares:576.54M
Float Shares:575.03M
Volume Ratio:1.56
T/O Rate:0.70%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.72
EPS(LYR):1.83
ROE:9.18%
ROA:8.37%
PB:4.93
PE(LYR):49.51

Loading ...

Edwards Lifesciences Is Maintained at Neutral by Baird

Dow Jones
·
Apr 24

Edwards Lifesciences price target lowered to $100 from $103 at BofA

TIPRANKS
·
Apr 24

Baird Adjusts Price Target on Edwards Lifesciences to $87 From $85, Maintains Neutral Rating

MT Newswires Live
·
Apr 24

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Sanofi (OtherSNYNF)

TIPRANKS
·
Apr 24

Edwards Lifesciences Shares up 2.2% Premarket After Q1 Revenue, Profit Beat

THOMSON REUTERS
·
Apr 24

U.S. RESEARCH ROUNDUP-Elevance Health, Huntington Bancshares, Monolithic Power Systems

Reuters
·
Apr 24

Edwards Lifesciences Corp : Canaccord Genuity Cuts Target Price to $85 From $87

THOMSON REUTERS
·
Apr 24

Edwards Lifesciences Corp : Truist Securities Raises Target Price to $90 From $89

THOMSON REUTERS
·
Apr 24

Edwards Lifesciences (EW) Gets a Buy from TD Cowen

TIPRANKS
·
Apr 24

Edwards Lifesciences beats quarterly estimates on robust demand for artificial heart valves

Reuters
·
Apr 24

Edwards Lifesciences Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Apr 24

Edwards Lifesciences Raises Full Year Outlook After 1Q Beat

Dow Jones
·
Apr 24

Edwards Lifesciences sees Q2 EPS 70c-76c, consensus 75c

TIPRANKS
·
Apr 24

Edwards Lifesciences Q1 sales rise 16.7%, beat estimates

Reuters
·
Apr 24

Edwards Lifesciences reports Q1 EPS 78c, consensus 73c

TIPRANKS
·
Apr 24

Edwards Lifesciences raises FY26 EPS view to $2.95-$3.05 from $2.90-$3.05

TIPRANKS
·
Apr 24

BRIEF-Edwards Lifesciences Q1 Adjusted EPS USD 0.78 Vs. IBES Estimate USD 0.73

Reuters
·
Apr 24

Edwards Lifesciences Q1 Adjusted EPS USD 0.78 VS. Ibes Estimate USD 0.73

THOMSON REUTERS
·
Apr 24

Edwards Lifesciences Corp FY2026 Shr View $2.93, REV View $6.68 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
Apr 24

Edwards Lifesciences Corp - Expects FY2026 Sales of $6.5-$6.9 Bln; Tavr Sales $4.7-$5.0 Bln

THOMSON REUTERS
·
Apr 24